TG Therapeutics | TGTX - 销售毛利



金融业
股票价格
USD
资产
USD 1.53B
现金及等价物
USD 442.21M
销售成本
USD 33.51M
流动资产
USD 1.09B
流动负债
USD 187.11M
债务
USD 253.71M
EBIT
USD 34.8M
EBITDA
USD 51.69M
员工
338
EPS每股收益
USD 0.12
股本和储备
USD 583.13M
销售毛利
USD 171.41M
债务利息支出
USD 7.67M
贷款资金
USD 745.14M
市值
USD 7.95B
净收入
USD 19.78M
营业费用
USD 170.12M
营业利润
USD 34.8M
普通股股本
USD 155.31M
PE价格收益
10.76
税前利润
USD 20.36M
销售收入
USD 194.8M
销售和管理费用
USD 73.14M
股票
USD 129.03M
贸易债权人
USD 148.85M
应收帐款人
USD 392.05M


销售毛利 更改 日
AbbVie USD 12.54B 474M 2026-03
Alaunos Therapeutics USD -1.13M 1.11M 2024-09
Amgen USD 6.89B 415M 2025-12
Ardelyx USD 114.37M 8.02M 2025-12
Arrowhead Research USD 264.03M 7.56M 2025-12
Bayer EUR 6.94B 1.58B 2025-12
Biogen USD 1.82B 169.5M 2026-03
Corcept Therapeutics USD 162.02M 37.56M 2026-03
Curis USD 1.14M 8.86M 2025-12
Gilead Sciences USD 5.52B 791M 2026-03
J&J USD 17.24B 642M 2026-03
Karyopharm Therapeutics USD 32.6M 63.38M 2025-12
Novartis USD 10.07B 184M 2026-03
Novavax USD 125.04M 76.09M 2025-12
PTC Therapeutics USD 232.94M 84.56M 2026-03
Puma Biotechnology USD 20.32M 24.85M 2024-09
Regeneron Pharmaceuticals USD 2.94B 363.7M 2026-03
Roche Holding CHF 22.09B 10.04B 2025-12
TG Therapeutics USD 171.41M 16.98M 2026-03
Verastem USD 14.64M 14.1M 2025-12
Vertex Pharmaceuticals USD 2.6B 121.7M 2026-03